Perez, Jaime Rubio, et al. “Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated With a Novel Combination Treatment With Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab)”. Archives of Clinical and Medical Case Reports, vol. 4, no. 1, Jan. 2020, pp. 8-14, https://fortunejournals.org/ojs/index.php/acmcr/article/view/22266.